Categories Earnings, Health Care

Earnings Summary: Highlights of Illumina’s Q2 2023 results

Biotechnology company Illumina, Inc. (NASDAQ: ILMN) on Wednesday announced financial results for the second quarter of 2023.

  • Second-quarter revenue came in at $1.18 billion, up 1% from Q2 2022; a 3% increase on a constant currency basis
  • Net loss per share was $1.48 in Q2, compared to a loss per share of $3.40 in the year-ago quarter
  • On an adjusted basis, it was earnings of $0.32 per share for Q2 2023, compared to $0.57 per share last year
  • The company expects fiscal year 2023 consolidated revenue growth of approximately 1%
  • It is looking for a loss in the range of $2.08 per share to $1.93 per share for fiscal 2023
  • Full-year adjusted earnings per share is expected to be in the range of $0.75 to $0.90

Most Popular

Infographic: How Spotify (SPOT) performed in Q2 2024

Spotify Technology S.A. (NYSE: SPOT) reported its second quarter 2024 earnings results today. Total revenue increased 20% year-over-year to EUR3.8 billion. Net income attributable to owners of the parent was

Philip Morris (PM) Q2 2024 Earnings: Key financials and quarterly highlights

Philip Morris International Inc. (NYSE: PM) reported its second quarter 2024 earnings results today. Net revenues increased 5.6% year-over-year to $9.5 billion. On an organic basis, revenues grew 9.6%. Net

LMT Earnings: Highlights of Lockheed Martin’s Q2 2024 financial results

Lockheed Martin Corporation (NYSE: LMT) Tuesday reported a year-over-year increase in net sales for the second quarter of 2024. The management raised its fiscal 2024 guidance. The aerospace company reported

Add Comment
Viewing Highlight